Wall Street Indexes Edge Higher as Middle East Peace Hopes Buoy Investor Sentiment CVS Coverage for Lillys GLP1 Drugs Could Expand Market Access for Millions Weak Dollar Dynamics How Currency Fluctuations Subsidize the US Oil Industry Bank of America Forecasts 10x Productivity Boost from AI as Implementation Gap Narrows Latin American Leaders at WUF13 Push for Housing Finance Reform and ClimateResilient Urban Development Piper Sandler Warns Strait of Hormuz Closure May Push Oil to New Highs This Summer THFF Q1 2026 Earnings Shares Slip Despite Narrow EPS Beat THCH Q4 2025 Earnings Deep Loss Reported Amidst Limited Disclosure ZSPC Q1 2026 Earnings Significant EPS Miss as Revenue Remains Undisclosed Acadia Healthcare Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Uptick NICE Q1 2026 Earnings EPS Beats Estimates Amid Cloud Momentum Stock Edges Lower Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress Ready Capital Corporation RC Slips to 181 Support Test in Focus Reinsurance Group of America Debenture RZC Holds Near Flat as Bond Market Weighs Rate Reset Features John Hancock Premium Dividend Fund PDT Edges Higher as YieldSeekers Take Notice Coherus Oncology Inc CHRS Rises 255 Key Levels to Watch After Support Hold JAKKS Pacific JAKK Holds Steady Near 2291 as Market Awaits Catalysts Taylor Swifts Chart Streak Stalled Alex Warrens Ordinary Blocks No 1 for 12th Week XMTR Q1 2026 Earnings EPS Beats Estimates Stock Reacts Positively Marathon Petroleum MPC Rises 2 as Refining Margins Drive Momentum Green Brick Partners GRBK Edges Higher as Homebuilder Shows Resilience Near Resistance Criteo CRTO Rallies Over 4 to 1787 Approaching Key Resistance Near 1876 Morgan Stanley Emerging Markets Debt Fund Inc MSD Holds Steady Near Resistance Amid Modest Uptick PEO Stock Slides 095 Testing Key Support Levels Amid Natural Resources Uncertainty Voyager Acquisition Corp VACH Surges 49 Potential Breakout From Consolidation Shoals Technologies Group SHLS Edges Higher by 103 Resistance in Sight as Solar Sector Finds Footing Inhibikase Therapeutics IKT Faces Selling Pressure as Stock Retreats to 169